Shares of Eli Lilly finished Thursday 3% higher despite an earnings report that showed sales of its blockbuster GLP-1 ...

NEW YORK — Most U.S. stocks rose Tuesday following an encouraging update on inflation, though drops for Eli Lilly and other influential stocks kept indexes in check. The Standard & Poor’s 500 ...

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

It turns out that the anti-obesity space isn't growing as fast as Eli Lilly or analysts anticipated, resulting in ...

Eli Lilly's Q4 FY24 guidance adjustment is due ... There are also some specific challenges related to the implementation of the Inflation Reduction Act (IRA) which come from the requirement ...

The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.

The markets have succumbed to the headline pressure around inflation and tariffs, with all three of the major stock market ...

New York – Most U.S. stocks rose Tuesday following an encouraging update on inflation, though drops for Eli Lilly and other influential stocks kept indexes in check. The S&P 500 rose 0.1% as ...

Stock Market Today: Wall Street Mostly Rises After Encouraging Inflation Data Despite Lilly's Drag NEW YORK (AP) — Most U.S. stocks rose Tuesday following an encouraging update on inflation ...

NEW YORK (AP) — Most U.S. stocks rose Tuesday following an encouraging update on inflation, though drops for Eli Lilly and other influential stocks kept indexes in check. The S&P 500 rose 0.1% ...